



INTRODUCTION                                                                
Major improvements in the diagnosis and treatment of congenital heart 
disease (CHD) have led to increased patient survival into adulthood. 
This has resulted in the greater prevalence of CHD in the general 
population.(1) A key component of the management of these patients is 
the requirement for life-long serial imaging. This allows investigation, and 
thus treatment, of the long-term sequelae of congenital heart disease, 
including late post-operative complications. 
Echocardiography remains the most commonly used tool for diagnosis 
and follow-up of patients with CHD. The strengths of this modality 
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include its ease of use, portability, and accuracy in assessing cardiac 
anatomy and function. However, echocardiography is limited by acoustic 
windows, provides poor images of distal vasculature and is highly 
operator-dependent. This is particularly the case in older children and 
adults, and in patients who have undergone multiple procedures. 
Therefore, cardiac catheterization remains an important component of 
both anatomic and functional assessment of patients with CHD. 
However, the clinical decision to proceed with such an investigation 
needs to be balanced with the risks associated with an invasive procedure, 
which also involves exposure to ionizing radiation. Furthermore, X-ray 
fl uoroscopy provides a projection image, from which complex three-
dimensional (3D) morphologies can be diffi cult to discern.
Thus, the development of alternative imaging modalities is desirable in 
order to improve management of these patients. Both magnetic 
resonance (MR) imaging and computed tomography (CT) are becoming 
increasingly important in the diagnosis and management of CHD 
(Figure 1). Such cross-sectional imaging techniques offer the ability to 
comprehensively assess cardiovascular anatomy and function. Further, 
these newer modalities also provide an avenue to devise novel “hybrid 
therapeutic options” where imaging can not only guide but also directly 
assist in the treatment of congenital lesions.
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The increasing prevalence of congenital 
heart disease (CHD) can be attributed to major improve-
ments in diagnosis and treatment. Although echo-
cardiography is the most commonly used imaging modality 
for diagnosis and follow up of subjects with CHD, the 
evolution of both cardiovascular magnetic resonance (MR) 
imaging and computed tomography (CT) does offer new 
ways to visualize the heart and the great vessels. The 
development of cardiovascular MR techniques such as spin-
echo and gradient-echo imaging, velocity-encoded phase 
contrast MR and gadolinium-enhanced MR angiography 
allow comprehensive assessment of cardiac anatomy and 
function. This provides information about the long-term 
sequelae of the underlying complex anatomy, hemodynamic 
assessment of residual post-operative lesions and 
complications of surgery.  As much of the functional data in 
CHD patients is usually acquired with invasive X-ray 
angiography, non-invasive alternatives such as cardiovascular 
MR and CT are desirable. This review evaluates the role of 
both these modalities in the management of subjects with 
CHD, particularly detailing recent developments in imaging 
techniques as they relate to the various CHD diagnoses we 
commonly encounter in our practice.
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FIGURE 1: Trends in cardiac imaging  
This graph demonstrates the trends in cardiac imaging at our institution, Great Ormond St 
Hospital for Children, in the period 2004-2006 (inclusive). Invasive catheter based 
investigations have decreased substantially; however, non-invasive imaging with both 
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This review discusses the use of both MR and CT in the diagnosis and 
management of various CHD conditions. In particular, specifi c 
techniques that have evolved to optimize image quality and acquisition 
will be highlighted.
MAGNETIC RESONANCE IMAGING                                    
MR imaging has been used for anatomical and functional evaluation of 
CHD for almost 20 years.(2-5) Some of the advantages of cardiovascular 
MR include a large fi eld of view, unlimited choice of imaging planes and 
low operator-dependency. In our practice, cardiovascular MR has an 
increasing role in the diagnosis and subsequent management of several 
forms of CHD (Figure 1). In the section below we detail the most 
common forms of CHD that benefi t from evaluation with cross-
sectional imaging. We will concentrate on aspects that are relevant to 
grown-up congenital heart disease (GUCH).
Specifi c Imaging Techniques
Spin echo “black blood” sequences were amongst the fi rst used in 
cardiovascular MR imaging and they still remain an important part of 
current imaging strategies.(6) In such sequences, fl owing blood is black 
because it does not experience both the initial RF pulse and the 
refocusing pulse. Thus, contrast is improved with spin-echo black blood 
imaging at sites of accelerated blood fl ow velocity. Consequently, this 
technique is particularly useful for the assessment of sites of vascular 
obstruction and valvar stenosis. Black blood imaging is also useful when 
imaging vessels after metallic stent insertion, as the refocusing pulse 
compensates for increased T2* effects. This is useful as the majority of 
stents are safe to image within the MRI environment.(7)
Gradient echo-imaging has revolutionized cardiovascular MR as it allows 
dynamic imaging of cardiac anatomy. Gradient sequences have shorter 
repeat times and therefore have higher temporal resolution. The fast 
acquisition enables multiple phases of the cardiac cycle to be acquired, 
which can then be reconstructed into a cine MR image representing 
one full cardiac cycle. Single-slice two dimensional (2D) balanced 
steady-state free precession (b-SSFP) imaging allows qualitative 
assessment of all cardiac chambers, valvar dysfunction, and dynamic 
vascular anatomy. This form of imaging is particularly useful in planning 
interventions, as it allows accurate measurements of lesion size over 
the entire cardiac cycle.(8) Multi-slice, 2D gradient echo imaging is 
currently regarded the best available in vivo method of assessing 
ventricular volumetry,(9) as it is not reliant on complex geometric 
models. 
Velocity-encoded phase-contrast MR enables accurate non-invasive 
blood fl ow quantifi cation in major vessels. Cardiac output, pulmonary-
to-systemic fl ow ratio and quantifi cation of gradients across stenoses 
and valvar regurgitation can all be accurately determined using this 
technique. Volume blood fl ow measured using this technique has been 
shown to be accurate when compared to both invasive oximetry(10) 
and fl ow-phantom experiments.(10) In the case of stenoses interrogation, 
excellent comparative data exists with Doppler echocardiography 
and catheter data.(11) The quantifi cation of regurgitant volume 
using this technique has been demonstrated to be superior to 
echocardiography.(12)
Gadolinium-enhanced MR angiography (Gd-MRA) relies on the T1-
shortening effect of dilute gadolinium and it has been shown to be 
useful in delineating thoracic vascular anatomy. Gadolinium imaging 
allows volume scans to be obtained within a breath hold, thus reducing 
respiratory artifact. Gd-MRA is useful in identifying stenotic vessels and 
correlates well with modalities such as X-ray angiography and surgical 
fi ndings.(13) It should be noted MRA imaging is not ECG-gated and thus 
dimensions measured from these images represent an average of 
dimensions throughout the cardiac cycle.
Tetralogy of Fallot 
Tetralogy of Fallot (ToF) (Figure 2) is the most common cyanotic 
congenital heart defect, with an incidence of approximately 420 per 
million live births.(14) Mal-alignment of the septum leads to right 
ventricular outfl ow tract (RVOT) obstruction, a sub-aortic ventricular 
septal defect (VSD) with aortic override, and right ventricular 
hypertrophy. Current management consists of early single-stage 
reconstructive surgery,(15) with staged reconstruction now reserved for 
cases with signifi cant hypoplasia of the central pulmonary arteries. (16) 
Gd-MRA of the pulmonary arteries correlates well with operative and 
conventional X-ray angiographic fi ndings and may be useful in 
determining the most appropriate corrective treatment strategy.(11, 17)
However, the main role of MR in patients with ToF is assessment of 
postoperative complications. Operative repair of ToF consists of 
resection of the infundibular stenosis, enlargement of the pulmonary 
valve/annulus and closure of the VSD. Pulmonary regurgitation due to 
previous RVOT/valvar surgery with transannular patch reconstruction 
of the RVOT/pulmonary annulus is the most common late post-
operative complication.(18, 19) Current strategies for the management of 
severe pulmonary regurgitation include surgical and trans-catheter 
approaches, which rely on accurate quantifi cation of regurgitation and 
defi nition of the RVOT anatomy.(20)
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2D spin-echo black blood and b-SSFP sequences can be used to defi ne 
RVOT anatomy and quantitatively assess RVOT dilatation or stenosis. 
Velocity-encoded phase-contrast MR can accurately quantify the degree 
of pulmonary regurgitation and has been internally validated against 
MR ventricular volumetry in patients with ToF.(12) In addition, 
velocity-encoded phase contrast MR can be used to measure peak 
velocities at the level of RVOT obstruction, and differential regurgitation 
in the branch pulmonary arteries.(21) These parameters have 
excellent correlation with fi ndings from echocardiography and catheter 
data.(11, 22)
MR assessment of right ventricular function is particularly important 
when determining the timing and evaluating the impact of invasive 
therapeutic strategies.(8, 23) Multi-slice short-axis b-SSFP imaging has 
been shown to be the most powerful method of quantifying ventricular 
function.(9) Furthermore, a combination of MR ventricular volumetry 
and tricuspid and pulmonary fl ow maps can be used to provide precise 
information about global and diastolic ventricular function.(24)
Pulmonary atresia, regarded as an extreme variant of ToF, is defi ned as 
a lack of continuity between the RVOT and the central pulmonary 
arteries, with a variable degree of hypoplasia of these structures. MR 
has a similar pre- and post-operative role in subjects with pulmonary 
atresia and a VSD as it does in ToF patients. Gd-MRA allows assessment 
of the central pulmonary arteries and major aorto-pulmonary collateral 
arteries (MAPCAs).(25) 3D visualization enhances surgical or inter-
ventional planning beyond the data provided by X-ray angiography. The 
post-operative functional quantifi cation of homograft regurgitation and 
stenosis is performed with velocity-encoded phase contrast MR, while 
black-blood imaging can be used to demonstrate stenosed conduits.(26) 
However, it should be noted that under-reporting of conduit stenosis 
due to calcifi cation is possible with this technique.(26) 
Transposition of the Great Arteries 
Transposition of the great arteries (TGA) (Figure 3) is the second-
commonest cyanotic CHD diagnosed in the fi rst year of life, with an 
incidence of 315 per million live births.(14) Currently, echocardiography 
is the imaging modality of choice for pre-operative diagnosis and assess-
ment. As in ToF, the main role of MR is in diagnosis of postoperative 
complications, particularly those that develop as the child grows older. 
Treatment for TGA patients was revolutionized with the introduction 
of the Senning procedure, in which an intra-atrial baffl e was used to 
divert blood from the right atrium to the left ventricle, and the left 
atrium to the right ventricle. A variation to the Senning procedure, the 
Mustard procedure uses a pericardial patch to construct the intra-atrial 
baffl e. However, although both these procedures produce a 
physiologically normal circulation, the patient is still left with a systemic 














A: Balanced-SSFP four-chamber image 
showing RV dilatation (triangle) in a 
patient with Tetralogy of Fallot (ToF). 
FIGURE 2
B: Volume-rendered 3D reconstruction 
from gadolinium-enhanced MR angio-
gram demonstrating pulmonary artery 
stenosis (arrow) in a patient with ToF.
C: Magnetic resonance phase-contrast ﬂ ow images through the main pulmonary artery (PA): Forward ﬂ ow in systole (shown as white) and diastolic ﬂ ow (shown as black) are depicted 
above. Flow is then plotted against time for the aorta and main PA, demonstrating pulmonary incompetence (regurgitant fraction=30%) in the lower panel.
200 400 600
Systole Diastole
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procedure of choice. In cases of TGA associated with a VSD and sub-
pulmonary stenosis, the Rastelli procedure is preferred.
Cardiovascular MR is not constrained by the intra-thoracic position of 
vessels and is ideal for imaging the RVOT and branch pulmonary 
arteries, the sites commonly where complications after the arterial 
switch procedure are identifi ed.(27, 28) Gd-MRA is used to visualize the 
3D anatomy, particularly the relationship between the pulmonary 
arteries and the aorta, while spin-echo sequences are used to accurately 
assess sites of stenoses. It has been shown that this combination of 
techniques is superior to echocardiography and compares favorably 
with conventional X-ray angiography in detecting signifi cant lesions.(29) 
Velocity-encoded phase contrast MR can be used to measure peak 
velocities at the level of the obstruction and calculate pressure gradients. 
This data has been shown to have a greater agreement with invasive 
pressure measurements than corresponding pressure gradients derived 
from Doppler ultrasound.(28) A less common complication of the 
arterial switch procedure is coronary stenosis secondary to the re-
implantation procedure. Although X-ray angiography represents the 
modality of choice, coronary MR angiography is particularly useful 
when assessing the proximal coronary arteries.(13)
Despite intra-atrial repair being superseded by the arterial switch 
operation, there are a signifi cant number of patients who have 
undergone either a Senning or Mustard operation. As the venous 
pathways have a complex 3D structure they are diffi cult to accurately 
assess with echocardiography. Gd-MRA can completely demonstrate 
the 3D Senning-Mustard anatomy and detect any luminal narrowing.(30) 
Spin-echo sequences can accurately measure static baffl e obstruction,(31) 
while 2D and 3D b-SSFP sequences can delineate dynamic anatomy of 
intra-atrial baffl es.(31) 
Aortic pathologies
Coarctation accounts for 6-8% of live births with CHD and refers to an 
area of narrowing of the thoracic aorta in the region of insertion of the 
arterial duct with or without additional abnormalities of the aortic 
arch.(32) Detailed serial follow up is mandatory as recoarctation occurs 
in 3-35% of surgically treated patients.(33) Added to this is the fact that 
a third of patients remain or become hypertensive as well as having an 
increased lifetime risk of atherosclerosis and end-organ damage. 
Although angiography has been regarded as the “gold standard” for the 
assessment of coarctation, MR imaging has been shown to be diagnostic 
and well suited for both pre- and post-operative evaluation.(34, 35)
Spin-echo imaging in the sagittal and oblique-sagittal planes provides 
excellent information of stenotic areas and collateral pathways.(36) 3D 
CE-MRA can display the severity and extent of involvement without 
spin dephasing artifacts and partial volume errors.(37) The severity of the 
stenosis at the level of the coarctation can be accurately determined 
using MR fl ow mapping.(38, 39) 
CE-MRA can be used to perform 3D post-processing techniques, 
which allow abnormalities to be viewed from different orientations. It 
should be emphasized that 3D MRA should be combined with at least 





Axial black-blood turbo-spin-echo imaging (A, B) and b-SSFP sagittal imaging (C) of transposition of the great arteries. The 
aorta (Ao) arises anteriorly from the hypertrophied right ventricle (arrow). The central pulmonary artery (PA) arises from the 
left ventricle. 
A B C
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the axial and sagittal oblique plane, in order to ensure that complete 
assessment of the aortic pathology is performed (Figure 4). 
MR imaging should also be used to identify other secondary pathologies 
in these patients, including: assessment for the presence of dilatation of 
the aorta: aortic valve stenosis and regurgitation; and quantifi cation of 
ventricular function and mass. MR follow-up after surgery or balloon 
dilatation allows accurate evaluation of recoarctation, residual stenosis, 
persistence of aortic arch hypoplasia and false aneurysm at the level of 
repair.(40, 41) Cine imaging of the heart should always accompany these 
studies, for detection of associated intra-cardiac lesions.(42)
Aortic dilatation and/or dissection are critical to both the diagnosis and 
prognosis of subjects with Marfan syndrome. MRI provides defi nitive 
measurements of aortic dimensions, which are essential for the diagnosis 
of aortic involvement and serial follow up measurements.(43) Dilatation 
usually commences at the sinuses of Valsalva and MR derived diameters 
are particularly important in monitoring the early stages of this disease. 
Diameters must, however, be related to normal values for age and body 
surface area.(44, 45) Added to this, MR also enables the assessment of 
aortic biophysical properties, such as decreased aortic distensibility and 
increased fl ow wave velocity, in the aorta distal to the aortic root. These 
parameters have been shown to be present prior to overt aortic 
dilatation in subjects with Marfan syndrome (Figure 5). 
Finally, there are an increasing number of patients being treated with 
aortic stents for both coarctation(46) and aneurysms.(47) Although these 
metallic implants are safe to image under MR, gradient echo sequences 
are prone to fi eld inhomogeneity effects (T2*) related to the presence 
of the stent. Black-blood imaging provides the solution to this, with T2* 
effects compensated for by the 180º refocusing pulse. Thus, patients with 
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FIGURE 5
A: 3D reconstruction of the aortic arch 
(gadolinium contrast angiography) showing 
a dilated aortic root and pseudo-coarctation 
in a patient with Marfan Syndrome. 
B: Sagittal section through the spinal cord 
(T2-weighted) showing dural ectasia.
FIGURE 4: MRI of aortic coarctation. Images from various subjects. 
A: Black-blood turbo-spin-echo oblique sagittal image 
through the aorta showing a tight discrete aortic 
coarctation at the aortic isthmus (arrow). 
B: Velocity map images of a more distal moderate 
coarctation (arrow). 
C: Volume-rendered 3D reconstruction of contrast-
enhanced MR angiography data in a third subject, 
showing severe coarctation (arrow) and multiple 
collateral vessels.
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FIGURE 7 
stents in-situ can still be assessed by MR, and restenosis, stent placement, 
stent and aortic wall morphology can be assessed(48) (Figure 6). 
Atrial Septal Defect 
Atrial septal defects (ASD) (Figure 7) are the most common congenital 
heart defects detected in adults, with an incidence of 941 per million live 
births.(14) The presence of an ASD allows left-to-right shunting, leading to 
atrial and ventricular dilatation, which can then predispose to arrhythmia 
and volume overload. ASDs are also an independent risk factor for 
thrombo-embolic stroke. Previously, surgical closure of ASDs was 
performed when there was the existence of a large left-to-right shunt, 
which led to RV overload, atrial dilatation and symptoms. The advent of 
transcatheter ASD closure techniques has resulted in a more aggressive 
management strategy.(49, 50) Small- to medium-sized ostium secundum 
defects are best suited to this approach, as a defi ciency of the anterior 
or postero-inferior rim of the defect precludes transcatheter closure.
FIGURE 6: Aortic coarctation stent imaging. 
A: Coronal images from an aortic CE-MRA showing 
signal loss at the site of a proximal descending aorta 
metallic stent (arrow).
B: Sagittal images from an aortic CE-MRA showing 
signal loss at the site of a proximal descending aorta 
metallic stent (arrow).
C: Oblique sagittal TSE black-blood image in the same 
patient clearly demonstrates that the stent is widely 
patent. The length of the stent is indicated by the 
arrowheads.
A: b-SSFP image through a secundum atrial septal 
defect. Note there is no posterior rim; precluding 
insertion of an ASD closure device. 
B: The dotted line is the plane for through-plane phase-
encode velocity ﬂ ow mapping. 
C: Instantaneous ﬂ ow-against-time curve, through the 
ASD. The total ﬂ ow through the ASD is 52 ml/beat in a 
left to right direction.
52 mL/sec
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Cardiovascular MR plays an important role in the diagnosis and pre-
interventional assessment of ASDs. In fact, MR fi ndings have been 
shown to be more powerful predictors of successful catheter closure 
than transoesphageal or transthoracic echo fi ndings.(51) Two-dimensional 
(2D) spin-echo black-blood sequences and gradient-echo sequences 
accurately defi nes ASD anatomy(52, 53) and correlates well with fi ndings 
at surgery.(54) Multi-slice 2D gradient-echo techniques can be used to 
assess dynamic 3D anatomy of the defect. Multi-planar reformatting of 
this data can produce image planes that are useful in planning 
interventional procedures(55) However, as multi-slice techniques suffer 
from poor through-plane resolution, 3D b-SSFP sequences with 
isotropic resolution have been developed to produce accurate multi-
plane reformatted images with no loss of resolution.(56) 
Pulmonary venous abnormalities, which often accompany sinus venous 
defects, are well defi ned on Gd-MRA(57) and this information can assist 
in surgical planning. Also, evaluation of the hemodynamic status of ASDs 
can be performed with cardiovascular MR. Quantifi cation of left-to-
right shunts using velocity-encoded phase-contrast MR compares well 
with invasive catheterization derived data.(10) Multi-slice SSFP short-axis 
imaging accurately quantifi es the degree of ventricular overload, 
information that is critical in determining the timing of invasive 
intervention.(9, 58)
Ventricular Septal Defect 
VSDs are the most common CHD defects, with an incidence of 3,570 
per million live births.(14) Cardiovascular MRI has the advantage of 
offering a non-invasive method of quantifying left-to-right shunts caused 
by VSDs. Velocity-encoded phase-contrast MR compares well with 
traditional invasive catheterization methods.(10) Added to this there is 
preliminary evidence to suggest that in certain situations combining 
phase-contrast MR and invasive pressure measurements is more 
accurate than traditional methods alone, which rely on the Fick 
principle.(59)
Cardiovascular MR provides accurate 2D and 3D images of the defect. 
Multi-slice 2D gradient-echo techniques can be used to assess the 
dynamic 3D anatomy of the defect. In addition, multi-planar reformatting 
of this data can be used to produce image planes that are useful in 
planning interventional procedures.(55) For example, the relationship of 
the VSD to valvar structures is an important consideration when 
deciding on transcatheter closure. Also, where there are multiple VSDs, 
palliative pulmonary artery banding adequacy(60) can be accurately 
determined using velocity encoded gradient-echo cine MR and has 
been shown to compare well with surgical and catheter fi ndings.
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Anomalous Coronary Arteries
Anomalous coronary artery origin and proximal course is a recognized 
cause of myocardial ischemia and sudden death.(61) Although X-ray 
angiography is regarded as the gold standard for evaluation of anomalous 
coronary arteries, fi ndings from MR angiography correlate well and 
eliminate exposure to X-ray radiation.(62) Additionally, cardiovascular 
MR can also be used to assess perfusion and infarct size,(63) which are 
powerful predictors of prognosis.
MR IMAGING PROTOCOL FOR CHD                             
The protocol below is a general protocol for imaging of CHD. It should 
be altered to answer clinical questions depending on patient anatomy.
1. Scouts scans
2. HASTE black-blood axial imaging
3.  Navigator echo gated True FISP 3D volume of whole heart and 
great vessels
4. 2D single-slice True FISP cine images
 a. Vertical long axis
 b. Four-chamber view
 c. RVOT in two planes
 d. LVOT in two planes
 e. Both branch pulmonary arteries
5.  2D multi-slice True FISP cine images – entirety of both ventricle in 
short-axis
6. 2D single-slice black-blood TSE imaging
 a. Branch pulmonary arteries
 b. Aortic arch
 c. Vascular stenoses
7.  Phase-contrast velocity mapping
 a. Main pulmonary artery through-plane
 b. Ascending aorta through-plane
 c. Vascular stenoses in-plane
8.  3D contrast-enhanced MR angiography of the thoracic great 
vessels
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THE ROLE OF COMPUTED TOMOGRAPHY IN CHD    
As discussed in the previous section, MR of the heart and great vessels 
is often used in the assessment of CHD, both in grown-up cases and 
more recently in neonates, infants and younger children.(33) However, 
with its increasing availability and utility, multi-detector computed 
tomography (MDCT) imaging is now becoming established as a further 
method of imaging CHD. The development of spiral(64,65) and 
subsequently MDCT(66, 67) enables the acquisition of data during a single 
breath-hold and during the fi rst pass of a contrast bolus, so that images 
can be reconstructed in any two-dimensional plane or in three 
dimensions. 
In our own practice, we currently use MDCT for the following 
indications in patients with CHD:
 Aortic pathology, in particular aortic arch vascular rings (+airways 
imaging) (Figure 8)
 Pulmonary artery anatomy (only if no functional information is 
required)
Post-operative systemic to pulmonary shunts – size and patency
 Pulmonary venous anatomy – total and partial anomalous 





 Vascular stent imaging (Figure 10)
 Contraindication to MR imaging – permanent pacemaker, cerebral 
aneurysm clips, etc.
MR Versus MDCT
A major advantage of the recent advances in CT technology (16-slice 
and 64-slice MDCT) over MR is the very rapid acquisition time. Imaging 
can now be performed in a comfortable single breath hold at the peak 
of the contrast bolus, reducing the need for general anesthesia and 
sedation in young children. Currently, it is our policy to perform MR 
imaging in children less than 7 years of age under general anesthesia. 
Thus, in this age group, when anatomical information alone is needed, 
we will perform a MDCT scan (unsedated or sedated). However, if 
quantifi cation of ventricular function or vascular fl ow (e.g. pulmonary 
incompetence) is required we will perform an MR scan under general 
anesthesia. For subjects older than 7 years of age, and no contra-
indications, we will perform MR imaging in the fi rst instance. If there are 
contraindications to MR imaging (permanent pacemaker, cerebral 
aneurysm clips, etc.) or when stent imaging is necessary (metal artifact 
on MR imaging), we will perform cardiovascular MDCT.
There are two main disadvantages of MDCT compared with MR 
imaging. The fi rst is the use of ionizing radiation. This can be kept to 
a minimum, by using low kV, low mAs acquisitions, with current 
modulation, and image acquisition over the minimal area of interest. 
Using such protocols, our mean dose for non-cardiac gated cardio-
vascular MDCT in children is 1.2 ± 0.57 mSv. This equates to 
approximately 60 chest radiographs (standard PA chest radiograph = 
0.02mSv) or 6 months of background radiation exposure (UK average 
background radiation = 2.2mSv per year).(68, 69) Furthermore, in critically 




CT image demonstrating tracheal compression from a complete vascular ring – double 
aortic arch. The oesophagus (diamond), right aortic arch (white arrow) and left aortic 
arch (black arrow) are shown.
FIGURE 9: Supracardiac total anomalous pulmonary venous drainage. 
A: 3D volume-rendered MDCT angiogram 
viewed from left anterior oblique showing 
a supracardiac total anomalous pulmonary 
venous drainage.
B: The pulmonary veins (arrow) drain into 
an ascending vein (triangle) and then into 
the brachiocephalic vein (“BCV”) and SVC 
which drains into the right atrium.
BCV
13059 SAHJ journal October.indd   29 11/8/07   9:33:45 AM
30
for general anesthesia or even sedation may be more crucial, as the risk 
of prolonged sedation may be greater than that of radiation.(67) The 
second disadvantage of current MDCT techniques is that easy 
quantifi cation of cardiac function (at high heart rates) and arterial fl ow 
are not possible, especially when compared with cardiac-gated MR imaging.
Importantly, as our GUCH population ages, patients will become more 
prone to ischemic heart disease. Over the next 5 years, MDCT will 
become increasingly used to assess the coronary arteries, and will 
probably be the best method to non-invasively investigate chest pain in 
this patient population.(70-72) 
Future prospects
MDCT scanning will undoubtedly become more rapid, with installation 
of 64-slice scanners, now beginning, and the development of 256-slice 
scanners in the near future. This will enable even faster data acquisition, 
improving spatial and temporal resolution. This should allow ECG-gated 
images of cardiac anatomy to be feasible even at high heart rates. The 
assessment of cardiac function will then be routinely possible. 
Furthermore, such equipment will facilitate accurate non-invasive 
assessment of coronary artery disease.
CONCLUSION                                                                      
The recent improvements in non-invasive cross-sectional cardiovascular 
imaging modalities (MR and CT) have resulted in a change in our 
approach to the assessment and follow up of patients with CHD. The 
precise role of these imaging modalities will evolve over time. Currently, 
our own clinical practice is to use echocardiography in all cases of CHD. 
However, echocardiography can be technically diffi cult to perform, 
providing sub-optimal imaging. In these situations we use cardiovascular 
MR to further defi ne CHD anatomy and physiology. This is particularly 
important prior to and following corrective surgical and interventional 
procedures. Cardiovascular MR is critical to the non-invasive assessment 
of ventricular/valvar function and blood fl ow through hemodynamically 
signifi cant lesions and shunts. We specifi cally use MDCT in the initial 
diagnostic assessment of great vessel anatomy in young subjects, 
especially in circumstances where functional information is not required. 
Finally we use cardiac catheterization/angiography if haemodynamic 
information is required (pulmonary vascular resistance studies), or if 
there is a high degree of suspicion of coronary artery stenoses. This 
approach can improve non-invasive diagnosis and reveal detailed 
anatomy that is important for both clinical decision-making and surgical 
planning.
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FIGURE 10
A: MDCT demonstrating stent fracture at the site of 
aortic coarctation.
B: Aortic stent fracture shown at high magniﬁ cation 
derived from MDCT imaging. 
C: Volume rendered MDCT image demonstrating stent 
fracture at the site of the previously treated aortic 
coarctation.
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